Why skin type changes everything
The most common mistake in acne scar treatment is recommending the same protocol to every patient regardless of skin tone. CO2 laser resurfacing produces excellent results for fair-skinned patients — and can cause post-inflammatory hyperpigmentation that is more visible and harder to treat than the original scars in patients with darker skin. Getting this wrong doesn't just fail to help. It actively makes the problem worse.
Skin type in this context refers to the Fitzpatrick scale — a six-point classification based on melanin content and UV response. Understanding where you fall on this scale determines which treatments are safe, which require modified protocols, and which should be avoided entirely. This is the starting point at every acne scar consultation at Plump Medical Spa in Newport Beach.
The Fitzpatrick scale — where do you fall?
Post-inflammatory hyperpigmentation (PIH) is darkening of the skin in response to inflammation or injury — including laser energy, microneedling, and chemical peels. Patients with more melanin (darker skin tones) produce more PIH in response to the same level of trauma. In serious cases, PIH from aggressive treatment is more visible and more persistent than the original acne scars. Proper skin type assessment prevents this outcome.
Treatment safety by skin type
Fair skin — Fitzpatrick I and II
Fair-skinned patients have the widest range of treatment options and the lowest PIH risk. Ablative CO2 laser, RF microneedling, IPL, and subcision are all appropriate. The limiting factor for this group is typically downtime tolerance and scar severity rather than safety. Fair skin responds exceptionally well to fractional CO2 laser — often the highest-yielding single treatment for moderate-severe scarring in this group.
The combination of subcision + Sculptra + CO2 laser is the recommended approach for fair-skinned patients with mixed rolling and boxcar scarring. It addresses tethering, volume deficit, and surface texture in a single session.
Medium skin — Fitzpatrick III and IV
Medium skin tones — including many Latino, Middle Eastern, Mediterranean, East Asian, and mixed-race patients — sit in the moderate PIH risk zone. CO2 laser is not off the table, but it requires careful consideration: conservative settings, a pre-treatment protocol with topical agents (hydroquinone, niacinamide, retinoids) for 4–6 weeks before treatment, and strict post-treatment sun avoidance.
RF microneedling is the preferred starting point for Fitzpatrick III–IV patients — it delivers results with meaningfully lower PIH risk because the energy bypasses the epidermis. After demonstrating how the skin responds to RF, a cautious CO2 session can be added if indicated. This stepwise approach protects the patient while still achieving meaningful improvement.
Subcision and Sculptra are fully safe for this group with no PIH risk, making the subcision combination protocol an excellent option for rolling scar treatment regardless of laser choice.
Dark skin — Fitzpatrick V and VI
Dark skin tones have the highest melanocyte activity and the highest PIH risk with any treatment that creates surface inflammation. This does not mean acne scar treatment is unavailable — it means the protocol must be selected carefully.
RF microneedling (PiXel8) is the primary recommendation for Fitzpatrick V–VI. The insulated needle design delivers radiofrequency energy below the epidermis, dramatically reducing PIH risk while still producing meaningful dermal remodeling and scar improvement. Results require more sessions (typically 4–6) but are achievable safely.
Subcision with Sculptra is fully safe for dark skin and highly effective for rolling and tethered scars. For patients with predominantly rolling scarring, this combination alone — without any laser — produces significant improvement with zero PIH risk.
Ablative CO2 laser is generally not recommended for Fitzpatrick V–VI without a compelling clinical justification and extremely conservative settings. The PIH risk is substantial and the resulting hyperpigmentation can be persistent and difficult to treat.
Skin type is a starting point, not a verdict. Individual healing response varies within every Fitzpatrick category — some type III patients have very low PIH risk, while some type II patients develop unexpected hyperpigmentation. A comprehensive consultation that reviews your personal history, any past PIH, and sun habits is more informative than Fitzpatrick type alone. Dr. Mortazavi assesses all of this before recommending any treatment protocol.